Srishty Vij, Sonam Kumari, Arun Kaushik, Kishalay Datta
This license
enables reusers to distribute, remix, adapt, and build upon the material in any
medium or format for noncommercial purposes only, and only so long as
attribution is given to the creator.
Snake envenomation is a common medical emergency in tropical regions and is typically associated with neurotoxic, hemotoxic, or myotoxic manifestations. Cardiovascular complications are rare but potentially life-threatening. Acute myocardial infarction (AMI) following snakebite is an uncommon and poorly understood phenomenon, often leading to diagnostic and therapeutic challenges in emergency settings. We report a rare case of acute myocardial infarction occurring after snake envenomation, which showed significant clinical improvement following timely administration of polyvalent snake antivenom along with standard supportive care. A middle-aged male patient presented to the emergency department with a history of snakebite, followed by chest pain, diaphoresis, and hemodynamic instability. Electrocardiography revealed ST-segment elevation consistent with acute myocardial infarction, while cardiac biomarkers were markedly elevated. The patient had no prior history of coronary artery disease or traditional cardiovascular risk factors. Early administration of snake antivenom resulted in rapid stabilization, improvement in electrocardiographic changes, and normalization of cardiac enzymes. This case highlights the importance of recognizing acute coronary events as a possible complication of snake envenomation. Early diagnosis and prompt antivenom therapy may play a crucial role in reversing myocardial injury and improving outcomes. Clinicians in snakebite-endemic regions should maintain a high index of suspicion for cardiac involvement in such patients.
Srishty Vij, Sonam Kumari, Arun Kaushik, et al. Antisnake Venom in Treatment of Acute Myocardial Infarction. Ind J Emerg Med. 2026; 12(2): 108-111
This license
enables reusers to distribute, remix, adapt, and build upon the material in any
medium or format for noncommercial purposes only, and only so long as
attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| January 16, 2026 | February 17, 2026 | June 30, 2026 |
Sunday 05 July 2026, 03:53:46 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | January 16, 2026 |
| Accepted | February 17, 2026 |
| Published | June 30, 2026 |
This license
enables reusers to distribute, remix, adapt, and build upon the material in any
medium or format for noncommercial purposes only, and only so long as
attribution is given to the creator.